Car-T vs. Bispecifics for Lymphoma: Using the Evidence to Sequence Treatments

[ad_1]

CU Most cancers Heart member Manali Kamdar, MD, affiliate professor of medicine-hematology at CU Faculty of Medication, outlined an evidence-guided strategy to sequencing CAR-T and bispecific antibody therapies on this inhabitants.

[ad_2]

Source link